The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of Immunovant Inc (NASDAQ: IMVT) was $14.46 for the day, down -4.55% from the previous closing price of $15.15. In other words, the price has decreased by -$4.55 from its previous closing price. On the day, 3.07 million shares were traded. IMVT stock price reached its highest trading level at $15.12 during the session, while it also had its lowest trading level at $14.01.
Ratios:
Our analysis of IMVT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.04 and its Current Ratio is at 6.04. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on March 03, 2025, initiated with a Hold rating and assigned the stock a target price of $20.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 16 ’25 when Barnett Eva Renee sold 2,993 shares for $14.89 per share. The transaction valued at 44,566 led to the insider holds 396,774 shares of the business.
Salzmann Peter sold 8,321 shares of IMVT for $123,900 on Apr 16 ’25. The Chief Executive Officer now owns 1,178,191 shares after completing the transaction at $14.89 per share. On Apr 09 ’25, another insider, Salzmann Peter, who serves as the Chief Executive Officer of the company, sold 28,094 shares for $12.99 each. As a result, the insider received 364,941 and left with 1,186,512 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMVT now has a Market Capitalization of 2573388288 and an Enterprise Value of 2081523456.
Stock Price History:
The Beta on a monthly basis for IMVT is 0.81, which has changed by -0.4945823 over the last 52 weeks, in comparison to a change of 0.017286062 over the same period for the S&P500. Over the past 52 weeks, IMVT has reached a high of $34.47, while it has fallen to a 52-week low of $12.72. The 50-Day Moving Average of the stock is -20.78%, while the 200-Day Moving Average is calculated to be -43.44%.
Shares Statistics:
IMVT traded an average of 1.80M shares per day over the past three months and 2237630 shares per day over the past ten days. A total of 147.20M shares are outstanding, with a floating share count of 68.30M. Insiders hold about 59.79% of the company’s shares, while institutions hold 49.43% stake in the company. Shares short for IMVT as of 1743379200 were 19685000 with a Short Ratio of 10.92, compared to 1740700800 on 15390952. Therefore, it implies a Short% of Shares Outstanding of 19685000 and a Short% of Float of 22.5.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
